EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies

被引：0
作者：
Francisco Beca
Kevin Kensler
Benjamin Glass
Stuart J. Schnitt
Rulla M. Tamimi
Andrew H. Beck
机构：
[1] Beth Israel Deaconess Cancer Center,Cancer Research Institute
[2] Beth Israel Deaconess Medical Center,Department of Pathology
[3] Harvard Medical School,Department of Epidemiology
[4] Harvard T.H. Chan School of Public Health,undefined
[5] Channing Division of Network Medicine,undefined
[6] Department of Medicine,undefined
[7] Brigham and Women’s Hospital and Harvard Medical School,undefined
来源：
Breast Cancer Research | / 19卷
关键词：
Benign breast disease; Breast Cancer; Risk; EZH2; Nurses’ Health Studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression
    Zhang, Yanhong
    Liss, Adam L.
    Chung, Eugene
    Pierce, Lori J.
    Kleer, Celina G.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 21 - 28
  • [42] Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression
    Yanhong Zhang
    Adam L. Liss
    Eugene Chung
    Lori J. Pierce
    Celina G. Kleer
    Breast Cancer Research and Treatment, 2016, 158 : 21 - 28
  • [43] Breast cancer risk assessment and risk perception on nurses and midwives in Bornova Health District in Turkey
    Ceber, Esin
    Sayer, Meral Turk
    Ciceklioglu, Meltem
    Cimat, Sunduz
    CANCER NURSING, 2006, 29 (03) : 244 - 249
  • [44] Active and passive smoking in breast cancer: Prospective results from the Nurses' Health Study
    Egan, KM
    Stampfer, MJ
    Hunter, D
    Hankinson, S
    Rosner, BA
    Holmes, M
    Willett, WC
    Colditz, GA
    EPIDEMIOLOGY, 2002, 13 (02) : 138 - 145
  • [45] Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
    Ma, Shao-Jun
    Liu, Yan-Mei
    Zhang, Yue-Lang
    Chen, Ming-Wei
    Cao, Wei
    BIOSCIENCE REPORTS, 2018, 38
  • [46] MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
    S Fujii
    K Tokita
    N Wada
    K Ito
    C Yamauchi
    Y Ito
    A Ochiai
    Oncogene, 2011, 30 : 4118 - 4128
  • [47] Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology
    Liu, Liang-Chih
    Chien, Yi-Chung
    Wu, Guo-Wei
    Hua, Chun-Hung
    Tsai, I-Chen
    Hung, Chih-Chiang
    Wu, Tsai-Kun
    Pan, Ying-Ru
    Yang, Shun-Fa
    Yu, Yung-Luen
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (06): : 1023 - 1028
  • [48] Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia - Results from the Nurses' Health Study
    Collins, Laura C.
    Baer, Heather J.
    Tamimi, Rulla M.
    Connolly, James L.
    Colditz, Graham A.
    Schnitt, Stuart J.
    CANCER, 2007, 109 (02) : 180 - 187
  • [49] Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
    Marotti, Jonathan D.
    Collins, Laura C.
    Hu, Rong
    Tamimi, Rulla M.
    MODERN PATHOLOGY, 2010, 23 (02) : 197 - 204
  • [50] miRNome Profiling Reveals Shared Features in Breast Cancer Subtypes and Highlights miRNAs That Potentially Regulate MYB and EZH2 Expression
    Correa, Stephany
    Lopes, Francisco P.
    Panis, Carolina
    Basili, Thais
    Binato, Renata
    Abdelhay, Eliana
    FRONTIERS IN ONCOLOGY, 2021, 11
12345